Brief: Oncocyte Corp Begins Manufacturing Transplant Blood Test
27/06/2023 14:05
June 27 (Reuters) - OncoCyte Corp OCX.O :
* ONCOCYTE CORP - BEGUN MANUFACTURING PROCESS FOR
DISTRIBUTABLE
VERSION OF ITS PATENTED TRANSPLANT TECHNOLOGY
* ONCOCYTE CORP - EARLY ACCESS FOR RUO KIT IS EXPECTED TO
OPEN IN
LATE Q4 2023
Source text for Eikon: ID:nGNX5Z0vrp
Further company coverage: OCX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Insight Molecular Diagnostics
See all newsBrief: Insight Molecular Diagnostics Enters Amendment No. 2 To Merger Agreement On Sept 15, 2026
Insight Molecular Diagnostics Inc reports results for the quarter ended June 30 - Earnings Summary
Insight Molecular Diagnostics Inc expected to post a loss of 24 cents a share - Earnings Preview
Insight Molecular Diagnostics Q1 loss narrows as costs drop
Brief: Insight Molecular Diagnostics Completes Key Milestones Advancing Graftassuredx Toward FDA Submission